Clinical study to evaluate the safety and efficacy of a new targeted radioactive drug treatment for advanced prostate cancer

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525244-14-00

Enrollment

Registered

2026-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic prostate cancer

None listed

Sex/Gender

Male

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Sep 16, 2026